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HF,ZlCOBACTER pylort is the most common cause of

gastroduodenal inflammation. However, the exact
immune pathogenesis is not fully understood. To
10ok for evidence of the immunological mechanism in H. pylori associated disease, we measured
cytokine interleukin-2 (IL-2) and IL-4 levels
produced by peripheral blood lymphocytes (PBL)
and gastric biopsies in 20 subjects with or without
H. pylori infection. H. pylort can stimulate IL-2
and IL-4 production from PBL in H. pylori
negative as well as H. pylort positive individuals.
The spontaneous IL-2 production by PBL and
gastric biopsies was greater (p < 0.0025, <0.001)
in H. pylori negative individuals than that in H.
pylori infected patients. Increased IL-4 levels from
PBL in H. pylori infected patients were found in
the presence of H. pylori (p < 0.0025). An
increased spontaneous production of IL-4 from
gastric biopsies was also observed in H. pylort
infected patients (p < 0.025). In conclusion, an
enhanced type 2 cytokine production was
observed in H. pylort infected patients, which may
be responsible for H. pylort chronic infection.
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Introduction
Helicobacter pylori are Gram-negative bacteria
that live in the human stomach. H. pylori infection is now recognized as one of the most
common chronic infections in man. Several lines
of evidence implicate /-/. pylori infection in gastroduodenal inflammation.- Colonization of the
gastric epithelium by the bacterium results in an
inflammatory reaction by both the humoral and
cellular immune responses. 4 In spite of some
established observations, the exact immune
factors that contribute to pathogenetic mechanisms of the disease and that sustain the chronic
colonization are not fully understood.
T-helper (TH) lymphocytes may be subdivided
into TH1 and TH2 subsets based on the distinct
profiles of cytokine production. TH1 cells
produce interferon-gamma (IFN-,) and interleukin-2 (IL-2) which are associated with immunity or resistance to infection; whereas TH2 cells
produce IL-4, IL-5, IL-6 and IL-10 cytokines which
are associated with progression or persistence of
infection. Type 1 cytokines stimulate cellomediated immunity and type 2 cytokines stimulate
humoral immunity. Cytokines produced by one
type of TH cells can down-regulate the other
type of TH cells. Enhanced TH2 reaction, which
has an immunosuppressive role in human infection, has been found. 5- To evaluate the respon(C) 1995 Rapid Science Publishers

sive conditions of TH1 and TH2 cells in subjects
with H. pylori infection, we measured IL-2 produced by TH1 cells and IL-4 produced by TH2
cells in supernatants from peripheral blood lymphocytes (PBL) and gastric biopsies in these

subjects.

Subjects and Methods
Subjects: Twenty subjects with dyspepsia attending for upper gastrointestinal endoscopy were
studied. None of the subjects had recently
received non-steroidal anti-inflammatory drugs,
bismuth compounds or antibiotics. Patients with
evidence of malignant disease or immunosuppression were excluded. A rapid urease test
(CLO-test, Delta West Ltd, Australia) and a histological examination by using a Giemsa stain were

applied for evaluating the status of H. pylori
infection. Subjects were designated as H. pylori
positive on the basis of CLO testing or histological examination by Giemsa stain. Of 20 subjects,
ten (seven men and three women; mean age 44.6
years, range 20-70) had H. pylori infection,
including six with duodenal ulcer and four with
gastritis alone. Ten (six men and four women;
mean age 46.8 years, range 22-67) were H.
pylori negative subjects with normal results of
gastrointestinal endoscopy and histology.
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H. pylori: H. pylori preparation was made by
sonicating a mixture of H. pylori bacterial cultures obtained from six patients (four with duodenal ulcer and two with gastritis alone) on ice
using 6 x 15 s, 100 watt pulses, with 30 s cooling
intervals, followed by irradiation at 4000 rads to
sterilize the preparation. It was then washed with
phosphate buffered saline (PBS) and stored at
_20C. 3,9

PBL: PBL were isolated by Ficoll-Hypaque
density-gradient centrifugation, washed and suspended in RPMI 1640 medium containing 100 U/
ml penicillin, 100 gg/ml streptomycin, 20mM Lglutamine and 10% fetal calf serum. The number
and viability of the isolated PBL were determined
using acridine orange/ethidium bromide (EB/
AO). PBL (2 x 105/well) were seeded into each
well of the 96-well plates. Duplicate cultures were
incubated with H. pylori (final concentration
30 l.tg/ml), phytohaemagglutinin (PHA, 10 gtg/ml
as positive control) or the medium alone,
respectively, at 37C in 5% CO2. After 72h
culture, supernatants were collected and stored
at -70C until cytokine assay.
Gastric biopsies: Multiple biopsy specimens were
obtained during upper gastrointestinal endoscopy from adjacent sites of the gastric antrum
for H. pylori histological examination, CLO-test
and incubation. Biopsies for incubation were
immediately washed twice with the medium and
then cultured in I ml of culture medium at 37C

Table 1. IL-2 levels in supernatants from lymphocytes (pg/ml)

IL-2

PHA

Spontaneous

H. pylori

H. pylori
negative subjects
19.80*
Median
11.96-25.52
Range
No.
10

102.9
58.32-155.3
10

30.38
20.75-47.24
10

H. pylori
positive subjects
14.38
Median
Range
10.12-21.18
No.
10

104.7
50.68-162.4
10

30.66
18.95-45.25
10

*p < 0.0025 vs. H. pylori positive subjects.

PHA or H. pylori stimulation in both of the two
groups (Table 1).
There was decreased IL-2 production in supernatants from cultured gastric biopsies in patients
with H. pylori infection when compared with
subjects without (Table 2).
IL-4 levels.. In the absence of PHA or /-/. pylori,
no significant difference was found for IL-4 levels
in supernatants from cultured PBL between H.
pylori negative and positive subjects. Stimulation
Table 2. IL-2 and IL-4 production in supernatants from cultured
gastric biopsies (pg/g wet wt)

(n= 10)

IL-4
(n= 10)

635.1"
359.1-1368

47.91"*
16.24-67.28

337.3
141.8-576.8

67.57
28.28-101.3

IL-2

in 5% CO2. Following a 24h incubation, supernatants were collected by centrifugation and
stored at -70 C until cytokine assay. 10

H. pylori
negative subjects
Median

Measurements of IL-2 and IL-4: IL-2 and IL-4
were measured by EIA Kits (Advanced Magnetics
Inc., Cambridge, MA, USA). Assays were performed in duplicate according to the manufac-

H. pylori
positive subjects
Median

turer’s instructions.

*p < 0.0025 or **p < 0.025 vs. H. pylori positive subjects, respectively.

Statistics: Data were expressed as medians and
ranges. Statistical analysis was carded out using
Mann-Whitney U-test.

Range

Range

Table 3. IL-4 level in supernatants from lymphocytes (pg/ml)
IL-4

Spontaneous

Results
IL-2 levels: H. pylori negative subjects had a significantl higher IL-2 level in supernatants from
resting PBL compared with those having H.
pylori infection. However, there was no sig-

nifican difference between these two groups in
IL-2 levels of supernatants from PBL, which were
stimulated with PHA or H. pylori although an
increase in IL-2 production was found following
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H. pylori
negative subjects
10.87
Median
5.92-15.24
Range

No.

10

H. pylori
positive subjects
11.86
Median
6.48-17.48
Range
10
No.

PHA

H. pylori

44.0
19.92-60.65
10

21.71
18.81-38.40
10

43.36
23.30-64.90
10

30.23
23.77-42.18
10

*p < 0.0025 vs. H. pylori positive subjects.

IL-2 and IL-4 in H. pylori

with /-L. pylori resulted in higher production of
It-4 from PBL in H. lylori infected patients than
that in/-L, pylori negative individuals. Although an
increase in IL-4 production was observed in
supernatants from PHA activated PBL in all subjects, IL-4 production was not significantly different between the two groups

(Table 3).

A significantly higher level of IL-4 in supernatants from cultured gastric biopsies was
observed in H. pylori infected patients compared
to H. pylori negative subjects (Table 2).
Discussion
Understanding host responses to infection
requires knowledge of the regulatory mechanisms that affect the outcome of infection by the
pathogen. The majority of individuals exposed
develop a powerful cellular immune response to
the pathogen, which results in elimination of the
infection. Some individuals are unable to mount
a sufficient immune response so that the infection proceeds unabated. A few studies have
reported that IL-4 has negative immunoregulatory
function in some infectious diseases, such as
acquired immunodeficiency syndrome, leprosy
and tuberculosis. 5’’12 Enhanced TH2 reaction
and down-regulation of the cellular immune
responses have been proposed in H. pylori
infected patients. ’1 The study showed that
increased IL-4 and decreased IL-2 production was
observed in PBL as well as in gastric biopsies
from H. pylori infected patients, providing
experimental evidence that enhanced TH2 reaction is present in H. pylori infected patients and
may play an important role in the immune
pathogenesis of H. pylori infection,
Microbial and host factors that affect the clearance of H. pylori from gastric tissue have not
been fully identified. Despite the fact that hosts
with H. pylori infection may have immune or
inflammatory responses to H. l/lori, the disease
still persists.’12 A TH1 to TH2 reaction shift may
be one of several important factors in this situation. Although the majority of people colonized
with H. pylori elicit strong, specific circulating
and gastric mucosal antibody responses, the
humoral response seems ineffective at eradicating
H. pylori. 14 15 Suppressed TH1 and enhanced
TH2 responses in H. pylori infection may imply
that the human host attempts to down-regulate
the inflammatory responses and reduce the tissue
injury because the intense inflammatory responses for the host per se are destructive. Some
hosts, on the other hand, are unable to eliminate
the bacterium due to suppressed cellular
immune responses. This may be one possible

infection

explanation why H. pylori infection is a chronic
condition, possibly lasting for decades, if not for
life.
It has been demonstrated previously that H.
pylori can activate PBL to release inflammatory
cytokines. 16’17 Also, a higher gastric cytokine concentration is present in /-L. pylori positive
patients. 18 In the present data, although PHA can
stimulate cytokine production from PBL, no significant difference was found between H. pylori
positive and negative groups in IL-4 production,
suggesting this may be a specific response to H.
pylori for H. pylori infected hosts. It has been
known that IL-4 can inhibit the synthesis of IFN-T
(type 1 cytokine). 9’2 Suppressed proliferative
responses of peripheral blood and gastric lymphocytes and decreased production of IFNq,
from PBL and gastric lamina propria lymphocytes
have also been demonstrated in patients with H.
pylori colonization, 6’2’22 implying that specific
T-cell responses are down-regulated by type 2
cytokines, and enhanced IL-4 profile is responsible for decreased production of IFN-T in H.
pylori infection. Further experimental observations will be required to investigate whether the
balance between TH1 and TH2 responses would
be restored by use of recombinant type 1 cytokines and anti-type 2 cytokine antibodies, or following eradication of H. pylori in the infected
patients.
More fundamentally, treatment of H. Iylori is
difficult because H. pylori’s habitat below the
layer of gastric mucus hinders the necessary
access of antimicrobials. Also, bacterial resistance
to antimicrobials is the main problem with
current treatment regimes. 2 Thus, antibacterial
treatment and effective immune responses will
both be of importance in the eradication of H.
pylori. We might be able to induce proper
immune responses in H. pylori positive hosts
and ultimately eradicate the bacterium. We might
use some agents to reduce the overproduction of
type 2 cytokines or to favour the secretion of
type 1 cytokines. The administration of recombinant type 1 cytokines could be beneficial to H.
pylori infected hosts. Anti-type 2 cytokine antibodies or type 2 cytokine receptor antagonists
could be used to restore the balance between
TH1 and TH2 responses in such patients and
thus eliminate the organism.
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